SUDEEP PHARMA LIMITED Share Price

SUDEEP PHARMA LIMITED Share Price

NSE: SUDEEPPHRM
|
Chemicals
|
S Cap
₹ 1,265.40
+₹31.40 (2.54%)
1D
Last updated 03 Sep, 2026, 09:17 IST

SUDEEP PHARMA LIMITED Share Price Today

As of 3 Sep 2026, SUDEEP PHARMA LIMITED share price is ₹1,265.40. The stock opened at ₹1,241.00, compared to its previous close of ₹1,234.00. During today's trading session, SUDEEP PHARMA LIMITED share price moved in the range of ₹1,240.10 to ₹1,266.00, with an average price of ₹1,253.05 for the day. Looking at its last 52-week, the stock has touched a low of ₹524.05 and a high of ₹1,292.40. On the performance front, SUDEEP PHARMA LIMITED share price has increased by 106.87% over the last six months and is up 59.40% on a year-on-year basis.

₹1,240.10
2.54% up today
₹1,266.00
1D LOW
1D HIGH

SUDEEP PHARMA LIMITED Returns Calculator

Circuit
L
H
₹1,172.30
₹1,295.70
52-week
L
H
₹524.05
₹1,292.40

About SUDEEP PHARMA LIMITED

SUDEEP PHARMA LIMITED Share Price
ISIN
INE0QPI01025
Sector Market Cap
₹ 13,821.5 Cr

Sudeep Pharma Private Limited is an India-based manufacturing pharmaceutical and nutraceutical products company. The Company is engaged in business of manufacturing and selling pharmaceutical and food, nutrition and specialty ingredients and intermediaries, used by pharmaceutical, food and nutrition industries globally. The Company a wide range of products, including mineral salts such as calcium salts, zinc salts, iron salts, potassium salts, magnesium salts, sodium salts, simethicone salts and copper salts. It offers products to a wide range of markets, which includes pharmaceuticals, dietary health, infant nutrition, beverage, dairy products, bakery products, confectionery, and staple food markets. Its subsidiaries include Sudeep Nutrition Private Limited, Sudeep Pharma USA Inc., Sudeep Pharma B.V., and Sudeep Advanced Materials Private Limited.

SUDEEP PHARMA LIMITED Financial Highlights

  • Revenue: SUDEEP PHARMA LIMITED reported revenue of ₹670.85 crore in FY26 vs ₹511.33 crore in FY25. It showed an increase of 31.20% on a yearly basis.
  • Operating Profit: SUDEEP PHARMA LIMITED reported an operating profit of ₹228.07 crore in FY26 vs ₹182.85 crore in FY25. It showed an increase of 24.73% on a year-on-year basis.
  • Net Profit: SUDEEP PHARMA LIMITED reported a net profit of ₹174.28 crore in FY26 vs ₹138.73 crore in FY25. It showed an increase of 25.63% on a yearly basis.

SUDEEP PHARMA LIMITED Quarterly Result Highlights

  • SUDEEP PHARMA LIMITED reported revenue of ₹163.72 crore in Jun 2026, compared with ₹188.76 crore in Mar 2026, representing a decrease of 13.27% on a quarter-on-quarter (QoQ) basis.
  • SUDEEP PHARMA LIMITED reported an operating profit of ₹54.29 crore in Jun 2026, compared with ₹62.69 crore in Mar 2026, representing a decrease of 13.40% on a quarter-on-quarter (QoQ) basis.
  • SUDEEP PHARMA LIMITED reported a profit of ₹40.59 crore in Jun 2026, compared with ₹48.54 crore in Mar 2026, reflecting a decrease of 16.38% on a QoQ basis.
  • The earnings per share (EPS) of SUDEEP PHARMA LIMITED stood at ₹15.50 during Jun 2026.
Know more
Promoters
76.15%
FII
1.81%
Other DII
10.17%
Retail and other
6.39%
Mutual funds
5.47%
Foreign institutions - FII
FII shareholding by period
Nov 20251.54%
Dec 20251.67%
Mar 20261.55%
Jun 20261.81%
Mkt Cap Cr
13,821.50
P/E
75.93
P/B
15.79
ROE
19.57%
D/E
0.16
ROCE
22.16%
Div. Yield
0.00%
EPS(TTM)
9.65
Turnover
0.37
EV/EBITDA
53.24
Net Margin
31.78%
Op. Margin
46.95%
ROA
15.63%
Quick Ratio
2.26
Curr. Ratio
8.52
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Sudeep Pharma outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Sudeep Pharma appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Sudeep Pharma earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Pidilite Industries1,66,566.0062.2415.3822.61%0.0329.97%104.780.70%0.9823.43
SRF76,535.4035.615.4813.07%0.2713.18%426.520.35%0.6558.18
Linde India54,415.5099.1712.7012.87%0.0217.16%495.720.19%0.4664.59
Gujarat Fluorochemicals52,062.9086.626.657.13%0.228.93%647.230.06%0.4761.69
Navin Fluorine44,312.5055.4811.0216.69%0.0318.14%714.370.10%0.5696.03
Godrej Industries38,847.4017.363.4311.10%6.259.34%52.520.00%0.361.81
Himadri Speciality Chemicals34,341.3041.427.0815.96%0.1619.45%91.620.12%0.7515.05
Deepak Nitrite24,328.4030.184.059.43%0.0210.74%235.740.42%0.7413.85
Aether Industries22,352.1092.898.908.94%0.1510.61%1,725.260.00%0.3313.09
Aarti Industries18,334.0034.533.087.04%0.836.41%164.640.20%0.7511.65

SUDEEP PHARMA LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹642.26₹502.00₹459.28₹428.74
Other Income₹28.59₹9.33₹6.10₹9.52
Total Revenue₹670.84₹511.33₹465.38₹438.26
Total Expenses₹442.77₹328.48₹290.56₹352.28
Profit Before Tax₹228.07₹182.85₹174.82₹85.98
Tax₹53.79₹44.12₹41.63₹23.66
Profit After Tax₹174.28₹138.73₹133.19₹62.32
EPS - Basic₹15.50₹12.79₹12.28₹5.74
EPS - Diluted₹15.50₹12.79₹12.28₹5.74

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹228.07₹182.85₹174.82₹85.98
Income before WC changes₹237.09₹198.30₹188.28₹103.89
Change in Assets-₹109.37-₹112.50-₹44.91-₹45.64
Change in Liabilities-₹2.70₹3.48-₹32.94₹12.57
Change in WC-₹112.07-₹109.02-₹77.85-₹33.07
Cash flow from Operations₹69.55₹48.73₹65.69₹48.40
Cash flow from Investing-₹330.93-₹78.76-₹49.28-₹50.02
Cash flow from Financing₹247.29₹52.70-₹12.74-₹9.78
Total Cash Flow-₹14.09₹22.67₹3.67-₹11.40
Cash (Start of the year)₹36.81₹13.98₹10.30₹21.47
Cash (End of the year)₹26.74₹36.81₹13.98₹10.30

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹550.91₹293.05₹238.50₹190.10
Current Assets₹623.97₹424.12₹275.37₹230.02
Total Assets₹1,174.88₹717.17₹513.87₹420.11
Current Liabilities₹201.96₹174.76₹137.22₹170.83
Net Current Asset₹422.00₹249.36₹138.14₹59.19
Non-Current Liabilities₹74.82₹49.32₹20.61₹26.00
Equity Capital₹898.09₹493.09₹356.03₹223.29
Total Equity & Liabilities₹1,174.88₹717.17₹513.87₹420.11

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹338.51₹356.73₹343.76₹404.00
Other Income₹38.50₹8.38₹8.20₹11.18
Total Revenue₹377.01₹365.11₹351.96₹415.17
Total Expenses₹231.91₹235.70₹219.65₹324.40
Profit Before Tax₹145.10₹129.41₹132.31₹90.77
Tax₹37.52₹33.66₹34.23₹23.60
Profit After Tax₹107.58₹95.75₹98.08₹67.17
EPS - Basic₹9.65₹8.82₹9.04₹476.69
EPS - Diluted₹9.65₹8.82₹9.04₹476.69

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹145.10₹129.41₹132.31₹90.77
Income before WC changes₹130.32₹138.37₹140.70₹103.31
Change in Assets-₹1.46-₹44.10₹6.91-₹54.18
Change in Liabilities₹5.15-₹5.44-₹52.33₹14.97
Change in WC₹3.70-₹49.54-₹45.42-₹39.22
Cash flow from Operations₹96.02₹59.15₹59.05₹42.31
Cash flow from Investing-₹366.68-₹91.59-₹40.67-₹40.71
Cash flow from Financing₹242.50₹54.20-₹16.14-₹10.11
Total Cash Flow-₹28.16₹21.75₹2.24-₹8.52
Cash (Start of the year)₹30.35₹8.59₹6.35₹14.87
Cash (End of the year)₹2.18₹30.35₹8.59₹6.35

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹515.83₹291.08₹219.85₹180.17
Current Assets₹457.95₹313.02₹230.75₹235.85
Total Assets₹973.78₹604.10₹450.60₹416.03
Current Liabilities₹145.07₹130.82₹104.51₹163.71
Net Current Asset₹312.88₹182.20₹126.24₹72.15
Non-Current Liabilities₹42.70₹43.16₹11.49₹15.44
Equity Capital₹786.01₹430.12₹334.60₹236.88
Total Equity & Liabilities₹973.78₹604.10₹450.60₹416.03
* All values are in INR Crore
Qty
Bid
5
1263.5
10
1263.4
19
1263
22
1262.4
3
1262.3
Ask
Qty
1265.4
3
1265.5
50
1265.9
23
1266
63
1266.4
1
Bid Total: 59
Ask Total: 140
Buy orders: 30%
Sell orders: 70%
Bearish
2
Neutral
4
Bullish
2
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
79.88
Bullish
ATR (14)
52.49
Neutral
STOCH(9,6)
69.25
Neutral
STOCH RSI (14)
95.97
Bearish
ADX(9)
87.06
Bearish
UO(9)
56.9
Neutral
ROC(12)
12.02
Bullish
WillR(14)
-27.5
Neutral
Period
Simple value
Exponential vaue
5D
1192.16
1200.54
10D
1156.79
1166.84
20D
1116.67
1109.41
50D
956.63
989.31
100D
832.17
890.34
Volume trend — traded volume by day
3 Sep0L
2 Sep3L
1 Sep3L
31 Aug3L
28 Aug1L
27 Aug1L
Average2L
Compare against other stocks
SUDEEP PHARMA LIMITED Share Price
SUDEEP PHARMA LIMITED
Chemicals
Add Stock
Add Another

SUDEEP PHARMA LIMITED Share Price FAQs